Biotech Values

[exwannabe]

More from biomedreports on HEB

http://biomedreports.com/articles/most-popular/1168-biggest-winners-become-biggest-losers-after-fridays-action-on-the-street.html

>>>
Missed by most HEB investors were two positive developments.

First, Reuters reported that Japan plans to produce enough H1N1 flu vaccine to treat 20 million people by the end of year. The company has been in discussions and testing their flu platforms with that country for quite some time.

“The highest level of the Japanese government and public medical community is now focused exclusively on our product,” Carter told BioMedReports last week. “They stopped working on all other adjuvants (boosters) and are only working with this one because they’ve found that it enhances the vaccines by 100 fold.”
>>>

The HEB scam machine is convincing the sheep that Japan will be ordering millions of doses of Ampligen within weeks. I kid you not.